Related Experiment Video
Updated: Feb 22, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
[New recommendations in oncocardiology].
Csaba András Nagy1, Mária Lódi2, Ingrid Balogh3
1I. Sz. Belgyógyászati és Kardiológiai Osztály, Uzsoki Utcai Kórház, Budapest, Hungary. nagycsaba@uzsoki.hu.
Modern cancer therapies improve survival but can harm the heart. Oncocardiology offers recommendations to manage cardiovascular side effects, optimizing cancer treatment outcomes and patient survival.
Area of Science:
- Cardiology
- Oncology
- Cardio-oncology
Background:
- Cancer therapies significantly reduce mortality but cause cardiovascular side effects.
- These side effects can limit treatment efficacy and impact long-term patient survival.
- Cardio-oncology is emerging to address these challenges.
Purpose of the Study:
- To present key recommendations for managing cardiovascular toxicity from cancer therapies.
- To optimize cancer treatment efficacy and patient outcomes.
- To guide clinical practice in cardio-oncology.
Main Methods:
- Review of current literature and clinical guidelines.
- Synthesis of evidence-based recommendations.
- Focus on practical management strategies for cardiovascular toxicity.
Main Results:
- Cardiovascular side effects are a significant concern in cancer patients.
- Early and late-onset toxicities require specific management approaches.
- Implementing cardio-oncology principles can mitigate risks.
Conclusions:
- Effective management of cardiovascular toxicity is crucial for cancer patients.
- Cardio-oncology recommendations aid clinicians in everyday practice.
- Optimizing cardiovascular health improves overall cancer treatment success and patient survival.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cardiomyopathy VI: Nursing Management
Tumor Immunotherapy